Literature DB >> 23381105

Long-term follow-up of TIPS created with expanded poly-tetrafluoroethylene covered stents.

Krishna C Sajja1, Bart L Dolmatch, Don C Rockey.   

Abstract

BACKGROUND: Transjugular intrahepatic portosystemic shunts (TIPS) created with expanded poly-tetrafluoroethylene-covered stents have largely replaced bare metal stents. Short-term shunt patency is typically assessed with protocol Doppler ultrasound (US), while little information exists with regard to long-term patency. AIM: We investigated the value of Doppler US in assessing TIPS patency as well as long-term clinical outcomes.
METHODS: A retrospective analysis of 59 patients with covered stents used for TIPS between January 2001 and December 2011 was performed.
RESULTS: Fifty-four patients had early (median 9 days) Doppler US follow-up. Seven of eight patients with an abnormal baseline US required stent revisions. None of the 46 patients with normal baseline Doppler US required revisions within the first 6 months; six of these patients subsequently had a portogram because of symptoms, but all TIPS were patent. Fifty-two patients survived for long-term (>6 months) follow-up, averaging 654 days and three Doppler US exams. Five of six patients with abnormal follow-up Doppler US required revisions, whereas none of the 46 patients with normal follow-up US had revisions. The recurrence of symptoms of portal hypertension and/or hepatic encephalopathy (HE) was low (4/52 patients). No significant predictors of long-term stenosis were identified. Post-TIPS HE was independent of pre-TIPS HE or Child-Pugh score.
CONCLUSIONS: Short-term patency and that at approximately 2 years after TIPS placement was 87 and 77 %, respectively. We conclude that Doppler US at least 1 week after TIPS is warranted, but repeated Doppler US follow-up is probably not necessary in the absence of clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381105     DOI: 10.1007/s10620-013-2578-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  A new stent-graft for transjugular intrahepatic portosystemic shunts.

Authors:  J D Rose; S Pimpalwar; R W Jackson
Journal:  Br J Radiol       Date:  2001-10       Impact factor: 3.039

2.  Comparative results of Doppler sonography after TIPS using covered and bare stents.

Authors:  Douglas Lake; Marcelo Guimaraes; Susan Ackerman; Christopher Hannegan; Claudio Schonholz; J Bayne Selby; Renan Uflacker
Journal:  AJR Am J Roentgenol       Date:  2006-04       Impact factor: 3.959

Review 3.  Doppler evaluation of transjugular intrahepatic portosystemic shunts.

Authors:  William D Middleton; Sharlene A Teefey; Michael D Darcy
Journal:  Ultrasound Q       Date:  2003-06       Impact factor: 1.657

4.  Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.

Authors:  S Masson; H A Mardini; J D Rose; C O Record
Journal:  QJM       Date:  2008-04-25

5.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

6.  Stent-grafts for revision of TIPS stenoses and occlusions: a clinical pilot study.

Authors:  R R Saxon; H A Timmermans; B T Uchida; B D Petersen; K G Benner; J Rabkin; F S Keller
Journal:  J Vasc Interv Radiol       Date:  1997 Jul-Aug       Impact factor: 3.464

7.  TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.

Authors:  Martin Rössle; Alexander L Gerbes
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

Review 8.  Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.

Authors:  Ming Bai; Xingshun Qi; Zhiping Yang; Zhanxin Yin; Yongzhan Nie; Shanshan Yuan; Kaichun Wu; Guohong Han; Daiming Fan
Journal:  J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 4.029

9.  Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.

Authors:  A J Sanyal; A M Freedman; M L Shiffman; P P Purdum; V A Luketic; A K Cheatham
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

10.  Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.

Authors:  Oliviero Riggio; Stefania Angeloni; Filippo Maria Salvatori; Adriano De Santis; Federica Cerini; Alessio Farcomeni; Adolfo Francesco Attili; Manuela Merli
Journal:  Am J Gastroenterol       Date:  2008-09-04       Impact factor: 10.864

View more
  5 in total

Review 1.  Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.

Authors:  Xing-Shun Qi; Ming Bai; Zhi-Ping Yang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

2.  Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.

Authors:  Fu-Liang He; Lei Wang; Zhen-Dong Yue; Hong-Wei Zhao; Fu-Quan Liu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

3.  Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.

Authors:  Chang-Ming Wang; Xuan Li; Jun Fu; Jing-Yuan Luan; Tian-Run Li; Jun Zhao; Guo-Xiang Dong
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

4.  Implantability, Complications, and Follow-Up After Transjugular Intrahepatic Portosystemic Stent-Shunt Creation With the 6F Self-Expanding Sinus-SuperFlex-Visual Stent.

Authors:  Daniel Spira; Jakub Wiskirchen; Ulrich Lauer; Dominik Ketelsen; Konstantin Nikolaou; Benjamin Wiesinger
Journal:  Iran J Radiol       Date:  2016-02-17       Impact factor: 0.212

5.  High Interleukin-8 Levels Associated With Decreased Survival in Patients With Cirrhosis Following Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Guofeng Liu; Xiaoze Wang; Tingting Yang; Yuling Yan; Tong Xiang; Li Yang; Xuefeng Luo
Journal:  Front Med (Lausanne)       Date:  2022-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.